TY - JOUR
T1 - Rimonabant
T2 - A cannabinoid receptor blocker for the treatment of metabolic and cardiovascular risk factors
AU - Tonstad, Serena
PY - 2006/3
Y1 - 2006/3
KW - Cardiometabolic
KW - Cardiovascular
KW - Endocannabinoid system
KW - Obesity
KW - Rimonabant
KW - Smoking cessation
KW - Hyperlipidemias/complications
KW - Cannabinoid Receptor Antagonists
KW - Humans
KW - Risk Factors
KW - Treatment Outcome
KW - Metabolic Syndrome/complications
KW - Diabetes Mellitus, Type 2/complications
KW - Clinical Trials, Phase III as Topic
KW - Pyrazoles/pharmacology
KW - Obesity/complications
KW - Piperidines/pharmacology
KW - Weight Gain/drug effects
KW - Tobacco Use Disorder/drug therapy
KW - Cardiovascular Diseases/etiology
KW - Smoking Cessation
UR - http://www.scopus.com/inward/record.url?scp=33644928428&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33644928428&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/55dbc494-4b52-3b9c-b14b-56e3919c305d/
U2 - 10.1016/j.numecd.2005.10.011
DO - 10.1016/j.numecd.2005.10.011
M3 - Review article
C2 - 16487916
AN - SCOPUS:33644928428
SN - 0939-4753
VL - 16
SP - 156
EP - 162
JO - Nutrition, Metabolism and Cardiovascular Diseases
JF - Nutrition, Metabolism and Cardiovascular Diseases
IS - 2
ER -